Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Sep. 21, 1998

Cangene files for German approval of next-generation WinRho product

Sep. 18, 1998

DNA immunization against rabies effectively protects nonhuman primates

Sep. 17, 1998

Aviron's FluMist PLA/ELA deemed nonfilable by FDA; resubmission planned

Sep. 15, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Licensing opportunity from the NIH: carrier for conjugate vaccines

Sep. 9, 1998

Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease

Sep. 8, 1998

Scripps patents guanine derivatives with immunostimulating activity

Sep. 4, 1998

Fujisawa announces marketing approval of Prograf in Mexico and launch in Taiwan

Sep. 3, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...